Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC (S)-Sunvozertinib | 2370013-49-1 | 99.1% | 584.08 g·mol⁻1 | C29H35ClFN7O3 | 5 MG
SDP

Catalog No. 5000262078
Encompass_Preferred

(S)-Sunvozertinib is the S-enantiomer of Sunvozertinib, a selective ErbBs (including mutant EGFR) and BTK inhibitor supplied as a solid research compound for in vitro and preclinical studies. It is intended for biochemical and cellular investigations of EGFR exon 20 insertion mutations and downstream signaling pathways.

  • High purity solid suitable for biochemical and cellular assays.
  • Molecular weight 584.08 g·mol⁻1 and formula C29H35ClFN7O3.
  • Available in small quantities for screening and preclinical studies.
  • Applicable for studies of EGFR and BTK signaling, including mutant variants.
  • Supplied with reported purity of 99.1%.

Catalog No. 50-002-62078 Supplier Medchemexpress LLC Supplier No. HY132842A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

(S)-Sunvozertinib is the S-enantiomer of Sunvozertinib, a selective ErbBs (including mutant EGFR) and BTK inhibitor supplied as a solid research compound for in vitro and preclinical studies. It is intended for biochemical and cellular investigations of EGFR exon 20 insertion mutations and downstream signaling pathways.

  • High purity solid suitable for biochemical and cellular assays.
  • Molecular weight 584.08 g·mol⁻1 and formula C29H35ClFN7O3.
  • Available in small quantities for screening and preclinical studies.
  • Applicable for studies of EGFR and BTK signaling, including mutant variants.
  • Supplied with reported purity of 99.1%.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.